Business
PharmaCielo to Hold Conference Call to Review Third Quarter 2020 Financial Results
PharmaCielo to Hold Conference Call to Review Third Quarter 2020 Financial Results ...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"\n \n \n \n PharmaCielo to Hold Conference Call to Review Third Quarter 2020 Financial Results\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n TORONTO and RIONEGRO, Colombia, Nov. 12, 2020\n \n \n \n \n \n \n \n TORONTO\n \n and RIONEGRO,\n \n Colombia\n \n ,\n \n Nov. 12, 2020\n \n /CNW/ -\n \n PharmaCielo Ltd.\n \n (\"\n \n PharmaCielo\n \n \" or the \"\n \n Company\n \n \") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that it will host a conference call on\n \n Monday, November 30\n \n \n th\n \n , 2020, at\n \n 8:00 a.m. ET\n \n to discuss its third quarter financial results and provide investors with key business highlights. The call will be chaired by\n \n David Attard\n \n , CEO and\n \n Scott Laitinen\n \n , CFO.\n \n \n \n \n \n \n \n \n \n \n CONFERENCE CALL DETAILS\n \n \n \n Date:\n \n November 30\n \n \n th\n \n , 2020 | Time:\n \n 8:00am ET\n \n \n \n Participant Dial-in: 416-764-8650 or 1-888-664-6383\n \n \n Replay Dial-in: 416-764-8677 or 1-888-390-0541\n \n \n Conference ID: 60606383\n \n \n Playback #: 606383 (Expires\n \n December 14, 2020\n \n )\n \n \n Listen to webcast:\n \n https://produceredition.webcasts.com/starthere.jsp?ei=1402171&tp_key=1965ad980c\n \n \n \n \n About PharmaCielo\n \n \n PharmaCielo Ltd. (TSXV: PCLO, OTCQX: PCLOF) is a global company, headquartered in Canada, with a focus on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal (and wholly owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its cultivation and processing centre located in Rionegro, Colombia.\n \n \n The board of directors and executive team of PharmaCielo are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise. Ph...